Rybelsus acts as an innovative treatment for Type 2 diabetes, harnessing the power of semaglutide, a GLP-1 receptor agonist. This medication lowers blood sugar levels through several mechanisms. It enhances insulin secretion when blood sugar levels rise, suppresses glucagon release, and slows gastric emptying, which contributes to a feeling of…